Allogene Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-0.68-0.65-0.84-1.43
Price/Sales ratio
38.866.291.190.68
Earnings per Share (EPS)
$-1.56$-1.63$-1.26$-0.74

Historical Multiples (2017 – 2023)

2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.47M-3.68-14.22-13.01-8.27-2.73-1.53-2.81-13.61
Price/Sales ratio
N/AN/AN/AN/A52.643.70K5.30K3.41K26.32
Price/Book Value ratio
-1.47M1.104.172.812.211.350.981.002.51
Price/Cash Flow ratio
N/A-17.45-19.11-26.39-10.96-4.08-2.11-3.03-22.75
Price/Free Cash Flow ratio
N/A-16.27-13.95-16.78-9.82-3.98-2.10-2.96-15.36
Price/Earnings Growth ratio
N/AN/A0.18-2.161.14-0.090.160.09-1.03
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/A66.05%-6783.95%-255598.94%N/A33.02%
Operating Profit Margin
N/AN/AN/AN/A-664.58%-138044.85%-344986.31%-121977.04%-332.29%
Pretax Profit Margin
N/AN/AN/AN/A-667.73%-136885.59%-344489.47%-121318.87%-333.86%
Net Profit Margin
N/AN/AN/AN/A-636.12%-135726.33%-344489.47%-121318.87%-318.06%
Effective Tax Rate
1200%0.05%0.17%6.69%4.73%0.84%N/AN/A5.71%
Return on Assets
N/A-27.33%-25.71%-19.01%-23.57%-40.36%-50.90%-29.10%-21.29%
Return On Equity
100%-30.07%-29.34%-21.62%-26.71%-49.53%-63.88%-31.05%-24.17%
Return on Capital Employed
100%-25.90%-29.50%-22.78%-25.82%-43.98%-54.10%-31.35%-24.30%
Liquidity Ratios
Current Ratio
N/A15.8816.468.96N/AN/AN/A9.699.33
Quick Ratio
N/A24.7718.2911.1517.2110.8412.389.4814.18
Cash ratio
N/A24.4817.8010.9416.8010.572.241.1313.87
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/A-63.74K-4.40K-6.54K-559.33-1.36KN/AN/A-5.47K
Operating Cycle
N/AN/AN/AN/A-559.33-1.36KN/AN/AN/A
Days of Payables Outstanding
N/A3.00K671.62328.59286.49303.078.86N/A307.54
Cash Conversion Cycle
N/AN/AN/AN/A-845.82-1.66K-8.86N/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/A0.18N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/A0.22N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.12N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
N/A-57.42N/AN/AN/AN/AN/A-132.15N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Company Equity Multiplier
N/A1.101.141.131.131.221.251.221.13
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/A-4.80-907.48-2.50K-1.12K-2.40
Free Cash Flow / Operating Cash Flow Ratio
N/A1.071.361.571.111.021.001.021.34
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A